Duramorph
NDC Package 60977-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Duramorph is a medication used to treat severe pain. Marketed by Baxter Healthcare Corporation, this product is identified by NDC 60977-017 and is authorized under FDA application NDA018565.

Identification & Billing

NDC Package Code
60977-017-01
Package Description
10 AMPULE in 1 PACKAGE / 10 mL in 1 AMPULE (60977-017-73)
Product Code
60977-017
11-Digit Billing Format
60977001701
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Duramorph
Dosage Form
-
Usage Information
This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Regulatory & Marketing

Labeler Name
Baxter Healthcare Corporation
FDA Application #
NDA018565
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-31-2010
End Marketing Date
02-28-2015
Listing Expiration
02-28-2015
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60977-017-01 identifies a specific commercial package of 10 ampule in 1 package / 10 ml in 1 ampule (60977-017-73) of Duramorph, labeled by Baxter Healthcare Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Baxter Healthcare Corporation on May 31, 2010. The current certification is valid through February 28, 2015.

What are the primary indications for this medication?

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

How is this Baxter Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60977001701. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60977-017-01
11-Digit CMS (5-4-2)
60977-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.